Stockholder’s Deficit (Tables)
|
3 Months Ended |
12 Months Ended |
Dec. 31, 2025 |
Sep. 30, 2025 |
| Equity [Abstract] |
|
|
| Schedule of Black-Scholes model |
| Schedule
of Black-Scholes model |
|
|
|
|
| |
|
August
6, 2025 - September 2, 2025 |
| Exercise
price |
|
|
3.27
- 9.09 |
|
| Risk-free
interest rate |
|
|
3.58
-3.91 |
% |
| Volatility |
|
|
101.4
- 114.4 |
% |
| Expected
life (years) |
|
|
3.19
- 5.00 |
|
| Dividend
yield |
|
|
0 |
% |
|
| Schedule
of Black-Scholes model | |
June
30,
2025 |
| Exercise
price | |
| 3.27
– 9.09 | |
| Risk-free
interest rate | |
| 3.58
– 3.91 | % |
| Volatility | |
| 101.4 – 114.4 | % |
| Expected
life (years) | |
| 3.19-5.00 | |
| Dividend
yield | |
$ | 0 | % |
The following is an analysis of the stock option grant
activity:
| Schedule
of stock option grant activity |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Number |
|
Weighted
Average Exercise Price |
|
Weighted
Average Remaining Life |
| Outstanding at September 30,
2024 |
|
|
|
— |
|
|
$ |
— |
|
|
|
— |
|
| Granted |
|
|
|
6,850,000 |
|
|
|
7.42 |
|
|
|
5.23 |
|
| Expired |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Exercised |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Outstanding at September 30,
2025 |
|
|
|
6,850,000 |
|
|
$ |
7.42 |
|
|
|
5.23 |
|
| Exercisable at September 30, 2025 |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
| chedule of stock option grant activity |
| Schedule
of stock option grant activity |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Number |
|
Weighted Average Exercise Price |
|
Weighted Average Remaining Life |
| Outstanding at September 30, 2024 |
|
|
|
— |
|
|
$ |
— |
|
|
$ |
— |
|
| Granted |
|
|
|
6,850,000 |
|
|
|
7.42 |
|
|
|
5.23 |
|
| Expired |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Exercised |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Outstanding at September 30, 2025 |
|
|
|
6,850,000 |
|
|
|
7.42 |
|
|
|
5.23 |
|
| Granted |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Expired |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Exercised |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Outstanding at December 31, 2025 |
|
|
|
6,850,000 |
|
|
$ |
7.42 |
|
|
$ |
4.98 |
|
|
| Schedule
of stock option grant activity |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Number |
|
Weighted
Average Exercise Price |
|
Weighted
Average Remaining Life |
| Outstanding at September 30,
2024 |
|
|
|
— |
|
|
$ |
— |
|
|
|
— |
|
| Granted |
|
|
|
6,850,000 |
|
|
|
7.42 |
|
|
|
5.23 |
|
| Expired |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Exercised |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
| Outstanding at September 30,
2025 |
|
|
|
6,850,000 |
|
|
$ |
7.42 |
|
|
|
5.23 |
|
| Exercisable at September 30, 2025 |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
| Schedule of recognize the remaining total stock-based compensation |
| Schedule
of recognize the remaining total stock-based compensation |
|
|
|
|
|
| Year |
|
Amount |
| 2026 |
|
|
$ |
6,029,541 |
|
| 2027 |
|
|
|
8,039,388 |
|
| 2028 |
|
|
|
8,039,388 |
|
| 2029 |
|
|
|
7,002,682 |
|
| 2030 |
|
|
|
7,683 |
|
| Total |
|
|
$ |
29,118,682 |
|
|
| Schedule
of recognize the remaining total stock-based compensation | | |
| | |
| Year | |
Amount |
| Remainder
of 2025 | | |
$ | 2,009,847 | |
| 2026 | | |
| 8,039,388 | |
| 2027 | | |
| 8,039,388 | |
| 2028 | | |
| 8,039,388 | |
| 2029 | | |
| 5,000,388 | |
| Total | | |
$ | 31,128,519 | |
|
| Schedule of RSU issuance and related stock-based expense |
| Schedule of RSU issuance and related stock-based expense | | |
| | | |
| | | |
| | |
| Quarter ended | |
RSU issued | |
Value of RSUs
issued | |
Stock based compensation |
| September 30, 2025 | | |
| 15,735 | | |
$ | 180,000 | | |
$ | 30,000 | |
| December 31, 2025 | | |
| — | | |
| — | | |
| 45,000 | |
| | | |
| 15,735 | | |
$ | 180,000 | | |
$ | 75,000 | |
|
|